Treatment Patterns in Advanced Small Cell Lung Cancer (SCLC)

Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments

NCT06448793 ·Status: RECRUITING

Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies

NCT06486428 ·Status: RECRUITING

Retrospective Epidemiological Study of Locally Advanced Non Small Cell Lung Cancer Patients in Brazil

NCT03836469 ·Status: COMPLETED

A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC)

NCT05170204 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage

NCT00168896 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Molecular Analysis and Treatment Options of SCLC

NCT05945745 ·Status: RECRUITING

An Observational Study of Lung Cancer Related Symptoms and Disease Control Rate in Patients With Non-Small Cell Lung Cancer Receiving First-Line Platinum-Based Chemotherapy With or Without Avastin (Bevacizumab)

NCT01358942 ·Status: COMPLETED

A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Extensive Stage Small Cell Lung Cancer

NCT05924841 ·Status: RECRUITING ·Phase: PHASE2

LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy

NCT00328588 ·Status: COMPLETED ·Phase: PHASE2

An Observational Study on Patients With Non-Squamous NSCLC Who Reached A Long PFS After Avastin (Bevacizumab)-Based First-Line Therapy

NCT01343914 ·Status: COMPLETED

Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer

NCT05384015 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC

NCT05765825 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of First-line Maintenance Erlotinib Versus Erlotinib at Disease Progression in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) Who Have Not Progressed Following Platinum-Based Chemotherapy

NCT01328951 ·Status: COMPLETED ·Phase: PHASE3

Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer

NCT00099879 ·Status: TERMINATED ·Phase: PHASE2

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

NCT04614103 ·Status: RECRUITING ·Phase: PHASE2

Efficacy of Re-challenge With Immune-Checkpoints Inhibitors in Advanced Non-Small-Cell Lung Cancer Patients: a Retrospective Observational Study

NCT04069663 ·Status: COMPLETED

Identification by Microarrays of the Risks of Metastatic Relapse, Toxicity and Resistance to Adjuvant Chemotherapy in Completely Resected Non-small Cell Lung Cancer

NCT02075957 ·Status: UNKNOWN

Early Hippocampal Avoidance Prophylactic Cranial Irradiation in Patients With LD SCLC

NCT02058056 ·Status: COMPLETED ·Phase: NA

Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer

NCT00622349 ·Status: COMPLETED ·Phase: PHASE3

Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens

NCT01721759 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Treatment Customized According to RAP80 and BRCA1 in Patients With Advanced Lung Carcinoma

NCT00617656 ·Status: TERMINATED ·Phase: PHASE3

RELEVANCE - RWE Study in Unresectable Non-Small Cell Lung Cancer (Stage III) in Canada

NCT05933044 ·Status: COMPLETED

Chemotherapy in Treating Patients With Lung Cancer

NCT01067794 ·Status: COMPLETED

Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

NCT00275132 ·Status: COMPLETED ·Phase: PHASE3

SCOT Registry: Small Cell Lung Cancer Treatment and Outcome

NCT00997061 ·Status: COMPLETED